Concepedia

Carlos Aya‐Bonilla

CA

Statistics

Publications

6

Citations

278

H-Index

6

Active since

2011

Affiliations

The University of Western Australia(Current)

Sir Charles Gairdner Hospital

Edith Cowan University

Harvard University

Government of Western Australia Department of Health

Carlos Aya‐Bonilla is an author at The University of Western Australia specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2011–2022

6

Publications

6

Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy

Laurence C. Cheung, Carlos Aya‐Bonilla, Mark N. Cruickshank et al. · Leukemia · 2022 · 66 citations · Full text

, , +15

Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells

Carlos Aya‐Bonilla, Michael Morici, Xin Hong et al. · British Journal of Cancer · 2020 · 60 citations · Full text

, , +17

Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device

Carlos Aya‐Bonilla, Gabriela Marsavela, James Freeman et al. · Oncotarget · 2017 · 58 citations · Full text

, , +14

Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non‐Hodgkin's lymphoma

Michael R. Green, Carlos Aya‐Bonilla, Maher K. Gandhi et al. · Genes Chromosomes and Cancer · 2011 · 52 citations

, , +17

High‐resolution loss of heterozygosity screening implicates <i>PTPRJ</i> as a potential tumor suppressor gene that affects susceptibility to non‐hodgkin's lymphoma

Carlos Aya‐Bonilla, Michael R. Green, Emily T. Camilleri et al. · Genes Chromosomes and Cancer · 2013 · 22 citations

, , +17

1–5 of 6